After Stopping Weight-Loss Drugs, Weight Can Return
Latest news on WhatsApp أجدد الأخبار على واتساب
Weight-loss medications such as semaglutide and tirzepatide have become a major part of obesity treatment for many patients. But the difficult question often comes after the early success: what happens when treatment stops? Official drug information and obesity guidelines are clear on one point: these medicines should not be stopped without medical advice, because they help manage weight and related health risks, but they do not “cure” obesity on their own.
Clinical data suggest that the main concern after stopping these drugs is not a classic “withdrawal syndrome,” but the gradual return of appetite, followed by weight regain and the possible loss of some of the health improvements achieved during treatment. MedlinePlus notes that weight-loss medicines often work only while they are being used, and continued follow-up matters when treatment changes.
In a follow-up analysis published on PubMed after semaglutide withdrawal, participants regained an average of 11.6 percentage points of the weight they had lost, while some cardiometabolic improvements also drifted back toward baseline. Another trial, SURMOUNT-4, found that adults who stopped tirzepatide experienced substantial weight regain, while those who stayed on treatment maintained and even extended their weight reduction.
That is why current Canadian obesity guidance treats anti-obesity medication as part of a long-term strategy rather than a short-term fix. Obesity Canada says clinical trials consistently show weight regain and regression of health improvements when treatment is stopped, and newer reviews have reached similar conclusions across GLP-1–based therapies. The practical message for patients is straightforward: if treatment is going to stop, it should happen with a physician-guided plan that includes nutrition, activity, and follow-up support, so early progress does not quickly unravel.
You May Also Like
Authors
-
Tahani Elghazaly5258 Posts
